17 results
8-K
EX-99.1
AGIO
Agios Pharmaceuticals Inc
12 Jul 22
Agios Appoints Brian Goff as Chief Executive Officer
4:14pm
,” said Dr. Fouse. “The time is right to evolve our leadership and deepen our genetically defined disease skill set to further drive our ability
DEFA14A
larica5j
21 Dec 20
Additional proxy soliciting materials
5:21pm
DEFA14A
EX-99.1
nrvwrt gzxpvs1du5xy
21 Dec 20
Additional proxy soliciting materials
7:10am
8-K
EX-99.1
ljd15zks0u
21 Dec 20
Regulation FD Disclosure
7:04am
S-3ASR
EX-4.4
9tayv vpg
30 Apr 20
Automatic shelf registration
4:19pm
S-3ASR
EX-4.5
67jeh4k wt
30 Apr 20
Automatic shelf registration
4:19pm
S-3ASR
mfyg0hzstmb
30 Apr 20
Automatic shelf registration
4:19pm
424B5
62rln
8 Nov 19
Prospectus supplement for primary offering
5:03pm
424B5
aexgo7pina06xfk go
6 Nov 19
Prospectus supplement for primary offering
4:07pm
424B5
tk7a9wnw9bt96l2roqrb
11 Dec 14
Prospectus supplement for primary offering
12:00am
424B5
pqrmk
9 Dec 14
Prospectus supplement for primary offering
12:00am
- Prev
- 1
- Next